🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Tirzepatide and sulfur burps: GIP receptor-mediated gastric effects — looking for input Page 5

Tirzepatide and sulfur burps: GIP receptor-mediated gastric effects — looking for input

MaxMetOK Wed, Feb 18, 2026 at 6:56 AM 27 replies 997 viewsPage 5 of 6
KevinCompounds
VIP Member
5,432
18,234
Dec 2023
Nevada
Feb 19, 2026 at 5:21 PM#21
DanielChem_CHI said:
Keep the original post as written when you update it, and add the correction underneath.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. Pushing back on the consensus forming here. Consistency is not the same as correctness, and a board that agrees with itself quickly is usually agreeing with the first person who sounded certain.

That is the short version; the long version is somebody else's post.

8 6jennifer_SEA, tyler_CSCS, VanRx_Mike and 5 others
Reply Quote Save Share Report
BrianDallas92
Member
312
1,456
Oct 2024
Dallas, TX
Feb 20, 2026 at 12:10 AM#22
DanielChem_CHI said:
Keep the original post as written when you update it, and add the correction underneath.

Agreed on the substance. I would put less weight on the timescale, because two months of anything is not enough to distinguish a trend from a wobble.

9 7mona_PHX, andrew_nyc, Dr.EndoEP and 6 others
Reply Quote Save Share Report
TomTeleRx
Member
189
678
Feb 2025
Delaware
Feb 20, 2026 at 6:59 AM#23
DanielChem_CHI said:
Keep the original post as written when you update it, and add the correction underneath.

That reframing is the part I needed. Printing the relevant bit and taking it with me.

Last edited: Feb 20, 2026 at 7:59 AM
10 8LibrarianMeg, bri_stats, pete_manc_UK and 7 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
lisa_labSD
Member
278
1,234
Oct 2024
San Diego, CA
Feb 20, 2026 at 1:48 PM#24

Adding the clinical framing, because it changes how the question reads. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

11 9lori_vegas, Dr.PulmRoch, maya_sedona and 8 others
Reply Quote Save Share Report
B12Beth
Member
289
890
Oct 2024
Maryland
Feb 20, 2026 at 8:37 PM#25
lisa_labSD said:
Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent…

This is my experience too, for whatever a second data point is worth. The detail I would add is minor and it is already implied above.

12 10pam_columbus, nick_SD_fit, ben_calgary and 9 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register